Pathogen Reduced Cryoprecipitated Fibrinogen Complex Visit product website ; INTERCEPT® Blood System for Platelets and Plasma Visit US SiteVisit International Site ; At Cerus, we are proud of our consistent and unwavering focus to secure blood safety around the globe. See Mission and Values ; Annual Report Cerus’ Annual Meeting of Stockholders will be held online on Wednesday, June 1, 2022 Read More Latest Press Releases 05/05/2022 Cerus Corporation Announces First Quarter 2022 Financial Results and Increases Full Year 2022 Product Revenue Guidance Range READ MORE 05/03/2022 Cerus Corporation Announces New Manufacturing and Supply Agreement With Fresenius Kabi For INTERCEPT Blood System Sets READ MORE 04/25/2022 Cerus Corporation Announces Multi-Year Contract for the INTERCEPT Blood System for Platelets with the American Red Cross READ MORE 04/21/2022 Cerus Corporation to Release First Quarter 2022 Financial Results on May 5, 2022 READ MORE view all press releases
